CDST_LT-M13: LC-DST
- CDST_LT: LT DST Introduction
- CDST_LT: Requirements for submission, acceptance and processing of isolates for DST
- CDST_LT: SIRE susceptibility testing
- CDST_LT: Pyrazinamide (PZA) susceptibility testing
- CDST_LT: Second line drug testing
- CDST_LT: Inoculum preparation and incubation for MGIT DST
- CDST_LT: Reading and reporting of MGIT 960 DST results
- CDST_LT: MGIT DST quality control
- CDST_LT: Quality assurance of TB Culture & DST laboratories
Ph-Module 2: TB Treatment
- Ph-Ch6: General concepts in TB Treatment
- Ph-Ch7: DS-TB Treatment and care
- Ph-Ch8: DR-TB Treatment and care
- Ph-Ch9: Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen
- Ph-Ch10: Longer Oral M/XDR-TB Regimen
- Ph-Ch11: Isoniazid (H) Mono/Poly DR-TB Regimen
- Ph-Ch12: TB Infection treatment and care
- Ph-Ch13: TB-Comorbidities and special situations
- Ph-Ch14: General Concepts in Adherence Managament